These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1044 related items for PubMed ID: 28269747

  • 1. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
    Gao P, Wang S, Jing F, Zhan J, Wang Y.
    Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
    [Abstract] [Full Text] [Related]

  • 2. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
    Chen DD, Cheng JT, Chandoo A, Sun XW, Zhang L, Lu MD, Sun WJ, Huang YP.
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug 01; 317(2):G147-G160. PubMed ID: 30943047
    [Abstract] [Full Text] [Related]

  • 3. Effect of Slug-Mediated Down-Regulation of E-Cadherin on Invasiveness and Metastasis of Anaplastic Thyroid Cancer Cells.
    Sheng L, Zhang S, Xu H.
    Med Sci Monit; 2017 Jan 10; 23():138-143. PubMed ID: 28070118
    [Abstract] [Full Text] [Related]

  • 4. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N, Du P, Zhang A, Shen F, Su J, Pu P, Wang T, Zjang J, Kang C, Zhang Q.
    Oncol Rep; 2013 Apr 10; 29(4):1579-87. PubMed ID: 23381389
    [Abstract] [Full Text] [Related]

  • 5. MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.
    Zheng J, Ge P, Liu X, Wei J, Wu G, Li X.
    Tumour Biol; 2017 Jun 10; 39(6):1010428317706207. PubMed ID: 28656883
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
    Zeng B, Shi W, Tan G.
    BMC Cancer; 2018 Jan 05; 18(1):34. PubMed ID: 29304764
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail.
    Zuo QF, Cao LY, Yu T, Gong L, Wang LN, Zhao YL, Xiao B, Zou QM.
    Cell Death Dis; 2015 Nov 26; 6(11):e2000. PubMed ID: 26610210
    [Abstract] [Full Text] [Related]

  • 13. MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer.
    Li J, Li T, Lu Y, Shen G, Guo H, Wu J, Lei C, Du F, Zhou F, Zhao X, Nie Y, Fan D.
    FASEB J; 2017 Sep 26; 31(9):3774-3786. PubMed ID: 28512191
    [Abstract] [Full Text] [Related]

  • 14. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
    Chen W, Wu J, Shi W, Zhang G, Chen X, Ji A, Wang Z, Wu J, Jiang C.
    Cancer Sci; 2021 Jun 26; 112(6):2158-2172. PubMed ID: 33587761
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
    Ge F, Wang C, Wang W, Liu W, Wu B.
    Oncol Rep; 2017 Aug 26; 38(2):1133-1139. PubMed ID: 28656284
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
    Xu M, Qin S, Cao F, Ding S, Li M.
    Int J Oncol; 2017 Sep 26; 51(3):867-876. PubMed ID: 28713929
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.
    Zhao X, Dou W, He L, Liang S, Tie J, Liu C, Li T, Lu Y, Mo P, Shi Y, Wu K, Nie Y, Fan D.
    Oncogene; 2013 Mar 14; 32(11):1363-72. PubMed ID: 22614005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.